Status:
COMPLETED
Postoperative Outcomes of PCNL vs RIRS in Obese Patients With Pelvic 1.5:3 cm Renal Stones
Lead Sponsor:
bassem metwally
Collaborating Sponsors:
Helwan University
Conditions:
Renal Stones
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This prospective randomized comparative study was done at Helwan University Hospital. It was conducted on 120 patients with unilateral pelvic renal stones from 1.5 to 3 cm in largest diameter who was ...
Detailed Description
In this study, 182 patients were assessed for eligibility; 62 patients were excluded, 48 of which were not meeting our inclusion criteria and 14 patients declined to participate in the study as detail...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Obese adult patients with body mass index ≥30
- aged ≥ 18 years
- unilateral pelvic renal stone from 1.5 to 3 cm in largest diameter.
- Exclusion criteria:
- A single kidney
- renal impairment (serum creatinine \> 1.4 mg/dl)
- patients with uncontrolled co-morbidities (hypertension, diabetes mellitus, cardiac disease, chest disease)
- active Urinary tract infection
- ureteric or bladder stones
- anatomic renal abnormalities (congenital renal malformations such as horseshoe kidney, polycystic kidney disease, etc.)
- people with severe skeletal deformity
- pregnant women
- history of ureteric strictures
- uncorrectable bleeding disorder.
Exclusion
Key Trial Info
Start Date :
December 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2022
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT06175910
Start Date
December 2 2020
End Date
September 15 2022
Last Update
December 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helwan University
Cairo, Helwan, Egypt, 22435